Minimally Invasive Spine Surgery Market to Reach 3.98 Billion by 2032

According to analysts at Vantage Market Research, the Minimally Invasive Spine Surgery Market size is worth 2.2 billion in 2023 and is projected to achieve 3.98 billion by 2032, growing at a CAGR (Compound Annual Growth Rate) of 6.8% from 2024 to 2032. The Minimally Invasive Spine Surgery Market is driven by increasing prevalence of spinal disorders, such as degenerative disc disease, herniated discs, and spinal stenosis as it fuels the demand for effective surgical interventions that minimize recovery time and improve patient outcomes.

Industry Overview

The Minimally Invasive Spine Surgery market is driven by the increasing incidences of spinal disorders. The incidence of spinal conditions such as herniated discs, spinal stenosis, and degenerative disc disease is on the rise in the geriatric population. These conditions often require surgical intervention, and minimally invasive techniques. MIS are increasingly preferred due to their advantages over traditional open surgeries. MIS procedures typically result in smaller incisions, less blood loss, reduced postoperative pain, and quicker recovery times. 

North America Dominated Sales with a 42.2% share in 2023.  North America's dominance can be attributed to the growing incidence of spinal disorders in the geriatric population, which has further increased demand for minimally invasive surgery (MIS) in North America and high adoption rates of modern medical technologies. For instance, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. The U.S. dominated the regional segment in terms of revenue on account of its established network of hospitals. In addition, highly competent surgeons who are increasingly opting for MIS procedures is proliferating the market growth.

Key Takeaway from the Report

• The Implants & instrumentation segment contributed a significant share to the market's growth in 2023 because of these components are crucial for the successful execution of minimally invasive spine surgeries
• By Application,Fusion Surgery dominated the market with market share of 60.2% due to effectiveness of fusion techniques in providing long-term relief and stability to patients, contributing to its widespread adoption and market dominance
• In 2023, North America led the market, capturing 42.2% market share due to the region's advanced healthcare infrastructure, high adoption of cutting-edge minimally invasive spine surgery technologies, and a significant prevalence of spinal disorders
• The Asia Pacific region is set for substantial growth, with a noteworthy projected CAGR throughout the forecast period 
• Baby Boomer spine surgeries are performed on majorly Spine surgeries are increasingly being performed on the Baby Boomer generation (Aged 60 to 78 years)
• The oblique and lateral lumbar spine surgeries are anticipated to experience greater growth compared to their posterior and transforaminal lumbar counterparts, though positive growth is expected all segments

Top Companies

• Medtronic plc
• Braun Melsungen AG
• MicroPort Scientific Corporation
• Aesculap Implant Systems LLC
• Alphatec Holdings Inc.
• RTI Surgical Holdings Inc.
• Orthofix Medical Inc.
• K2M Group Holdings Inc.
• SeaSpine Holdings Corporation
• CoreLink LLC
• NuVasive Inc.
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Globus Medical Inc.
• DePuy Synthes (Johnson & Johnson)

Latest News

Pioneering Endoscopic Spine Surgery: A Next-Generation Solution for Rapid Recovery

• In 2024, An innovative ultra-minimally invasive procedure known as endoscopic spine surgery (ESS) is now available in Chicago, performed by Dr. Kern Singh of Midwest Orthopaedics at RUSH for the patients requiring spine surgery. As a pioneer in this advanced technique, Dr. Singh is at the forefront of what is considered the 'next generation' of minimally invasive spine surgery 

Medtronic Secures CE Mark Approval for Affera Mapping and Ablation System for Atrial Arrhythmias

• In 2023, Medtronic received CE Mark approval for its Affera Mapping and Ablation System. This advanced system is designed to address atrial arrhythmias, offering precise mapping and ablation capabilities to assist healthcare professionals in effectively treating cardiac rhythm disorders.

Wenzel Spine Introduces S-LIF Procedure for Lumbar Interbody Fusion Using VariLift-LX Device

• In August 2022, Wenzel Spine, Inc., a medical technology company specializing in minimally invasive surgical and diagnostic solutions for spinal disorders, introduced the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion using the VariLift-LX device

Nexus Spine Launches Stable-C Cervical Implants with Integrated Anchoring Blades

• In July 2022, Nexus Spine, a developer of biomechanically advanced solutions for spinal pathologies, launched its Stable-C cervical interbody fusion implants, which feature integrated anchoring blades